categories
HOT TOPICS
- The Accelerator Conundrum
- The Startup Velocity Question
- Platform as a Service
- Man and Superman
- Web 3.0 = (4C + P + VS)
- The Future: End of Capitalism
- Capitalism 2.0
tarek sherif
Thought Leaders in Healthcare IT: Tarek Sherif, CEO of Medidata (Part 6)
Sramana Mitra: Have you started monetizing that? Have you started offering products on top of the datasets? Tareq Sherif: We actually have. Sramana Mitra: Give me an example. Tareq Sherif: There’s something called a synthetic control arm. In pretty much every clinical trial, you randomize patients. A patient comes in and you get put into
Thought Leaders in Healthcare IT: Tarek Sherif, CEO of Medidata (Part 4)
Sramana Mitra: What you just said is very interesting from a computer science point of view. So far, it seems like pharma has been developing drugs with clinical trials that have relatively small numbers of people whose data is going into trial input. The big data opportunity is to do this at a much higher
Thought Leaders in Healthcare IT: Tarek Sherif, CEO of Medidata (Part 5)
Sramana Mitra: You put in context what might happen with the existing workflow of the drug development as we introduce more capability from a scalability point of view. Instead of a drug going through three or four stages of clinical trials, maybe it will go through five or ten stages of clinical trials going into
Thought Leaders in Healthcare IT: Tarek Sherif, CEO of Medidata (Part 2)
Sramana Mitra: If you look at all the things that they’ve been doing and all the product roadmap announcements that they’ve made, they’re going into clinical trials in a big way. That’s why I asked you the question. Historically, they have come out of CRM but clinical research organizations and clinical trials has been one
Thought Leaders in Healthcare IT: Tarek Sherif, CEO of Medidata (Part 3)
Sramana Mitra: We have a little company within the 1Mby1M program called CleaningUp. Their discovery is that, as you said, a huge percentage of the workflow of drug development is still on paper and not digital. Especially when trials are held in international locations, people fill out papers. They’re trying to transform that process into
Thought Leaders in Healthcare IT: Tarek Sherif, CEO of Medidata (Part 1)
The clinical data domain is going through major changes and is full of opportunities. This discussion delves into the industry with one of its biggest players. Sramana Mitra: Let’s introduce our audience to you as well as Medidata. Tarek Sherif: I’m Tarek Sherif. I’m a Co-Founder, the CEO, and Chairman of Medidata Solutions. We’re a
